Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Allergan Aesthetic Medicines Head Moatazedi Moves To Emerging Competitor Evolus

Syringes stuck in a dartboard

Related Content

Allergan Pays $2bn-Plus For Zeltiq, Expanding Aesthetics Business

Feb 13 2017

Pipeline Watch: Topline Phase III Results For Tenapanor, Abemaciclib

Oct 13 2017

Revance's Long-Acting RT002 Will Have Slow-Moving Impact On Allergan

Dec 06 2017

Mylan Poised To Launch Its First US Biosimilar, With A Stacked Pipeline Behind It

Apr 12 2018

Mylan Set To Develop Biosimilar Botox In Deal With Revance

Mar 01 2018

Finance Watch: Biopharma IPOs Defy Broader Stock Performance Trends

Mar 09 2018

Daewoong Strikes New Deal For Botox Rival

Mar 29 2015

Related Companies

Allergan plc

Evolus, Inc.

Daewoong Pharmaceutical Company Ltd.

Revance Therapeutics, Inc.

Viatris Inc.

Galderma S.A.

Additional Topics

Leadership Business Strategies Companies Market Access Commercial Aesthetics BioPharmaceutical

More from Leadership

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window